
Tobacco control efforts protect 6.1 billion people: WHO Global Tobacco Epidemic report
The World Health Organization (WHO) on Monday released its report on the Global Tobacco Epidemic 2025, warning that action is needed to maintain and accelerate progress in tobacco control as rising industry interference challenges tobacco policies and control efforts. The report released at the World Conference on Tobacco Control in Dublin focuses on the six proven WHO MPOWER tobacco control measures to reduce tobacco use, which claims over 7 million lives a year.(AFP)
The report that was released at the World Conference on Tobacco Control in Dublin focuses on the six proven WHO MPOWER tobacco control measures to reduce tobacco use, which claims over 7 million lives a year: Monitoring tobacco use and prevention policies; Protecting people from tobacco smoke with smoke-free air legislation; Offering help to quit tobacco use; Warning about the dangers of tobacco with pack labels and mass media; Enforcing bans on tobacco advertising, promotion and sponsorship; and Raising taxes on tobacco.
Since 2007, 155 countries have implemented at least one of the WHO MPOWER tobacco control measures to reduce tobacco use at best-practice level, according to the report. India data show, the country has achieved complete measures in two of these categories— Offering help to quit tobacco use and Warning about the dangers of tobacco with pack labels and mass media— and moderate measures in the rest of the four categories.
Today, over 6.1 billion people, three-quarters of the world's population, are protected by at least one such policy, compared to just 1 billion in 2007, the report said.
Four countries have implemented the full MPOWER package: Brazil, Mauritius, the Netherlands (Kingdom of the), and Türkiye. Seven countries are just one measure away from achieving the full implementation of the MPOWER package, signifying the highest level of tobacco control, including Ethiopia, Ireland, Jordan, Mexico, New Zealand, Slovenia and Spain.
However, there are major gaps. Forty countries still have no MPOWER measure at best-practice level and more than 30 countries allow cigarette sales without mandatory health warnings.
'Twenty years since the adoption of the WHO Framework Convention on Tobacco Control, we have many successes to celebrate, but the tobacco industry continues to evolve and so must we,' said Tedros Adhanom Ghebreyesus, WHO director-general. 'By uniting science, policy and political will, we can create a world where tobacco no longer claims lives, damages economies or steals futures. Together, we can end the tobacco epidemic.'
The report reveals that the most striking gains have been in graphic health warnings, one of the key measures under the WHO Framework Convention on Tobacco Control, that make the harms of tobacco impossible to ignore. Hundred and ten countries now require them — up from just 9 in 2007 — protecting 62% of the global population; and 25 countries have adopted plain packaging.
WHO warns, however, that enforcement is inconsistent, and smokeless tobacco packaging remains poorly regulated. 'Despite their effectiveness, 110 countries haven't run anti-tobacco campaigns since 2022. However, 36% of the global population now lives in countries that have run best-practice campaigns, up from just 19% in 2022,' read the report.
'Taxes, quit services and advertising bans have been expanding, but many improvements are needed: Taxation: 134 countries have failed to make cigarettes less affordable. Since 2022, just 3 have increased taxes to the best-practice level. Cessation: Only 33% of people globally have access to cost-covered quit services. Advertising bans: Best-practice bans exist in 68 countries, covering over 25% of the global population.'
Around 1.3 million people die from second-hand smoke every year. Today, 79 countries have implemented comprehensive smoke-free environments, covering one-third of the world's population. Since 2022, six additional countries (Cook Islands, Indonesia, Malaysia, Sierra Leone, Slovenia and Uzbekistan) have adopted strong smoke-free laws, despite industry resistance, particularly in hospitality venues.
There has been a growing trend to regulate the use of e-cigarettes or ENDS, Electronic Nicotine Delivery Systems. The number of countries regulating or banning ENDS has grown from 122 in 2022 to 133 in 2024, a clear signal of increased attention to these products. However, over 60 countries still lack any regulations on ENDS, the report said.
'Governments must act boldly to close remaining gaps, strengthen enforcement, and invest in the proven tools that save lives. WHO calls on all countries to accelerate progress on MPOWER and ensure that no one is left behind in the fight against tobacco,' said Ruediger Krech, director of health promotion, WHO.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hindustan Times
22 minutes ago
- Hindustan Times
Digital well-being in 2025: Can tech help us unplug or is it making us more addicted?
In 2025, digital well-being isn't just an app, it's a conversation. A contradiction, really. On one hand, tech giants are rolling out smarter tools to help us unplug. On the other, screen time has never been higher, and tech dependency is now a formal health concern. So the question is: are we reclaiming control, or just learning to live with our digital leash? Ensuring digital well-being in 2025 The numbers tell a story. Most adults and teenagers in India and globally are clocking anywhere between 7.5 to 9 hours of screen time per day. That's nearly one-third of a full day, and it's taking a toll. Studies link this overexposure to poor sleep, rising stress levels, and mental health dips, especially in adolescents. In 2024, the World Health Organization officially recognized 'digital dependency disorder'. A move that turned what felt like a first-world worry into a global public health issue. Digital well-being tools: What's new in 2025 What started as screen-time counters on phones has now evolved into AI-powered wellness ecosystems. Google's Digital Wellbeing app tracks everything. From how many times you unlock your phone to app timers that nudge you to take a break. Focus and Bedtime modes mute distractions when you need to disconnect. Apple's Focus Mode goes a step further by using AI to predict when you're slipping into distraction loops and gently pulling you back. Then there are wearables like the Oura Ring 4 or Muse 2 that track real-time stress, sleep quality, and even prompt breathing exercises when your heart rate spikes. Digital mental health platforms like Calm, InnerAI, and even VR therapy rooms are seeing traction for users who want structured ways to decompress without logging off entirely. Some studies show that using these tools can help reduce screen time by up to 42% in just three months. That's promising, but only if people stick with it. Are we unplugging or just managing addiction? Here's where it gets nuanced. Digital well-being in 2025 isn't about cutting tech out. It's about using tech with intention. Experts call it a shift from 'disconnecting' to 'realigning.' The goal is to match your device use with your personal values, whether that's family time, focused work, or better sleep. Tech-free retreats, analogue journals, and even offline Sundays are gaining popularity, especially among Gen Z and young professionals. Still, compulsive use remains a problem for many, suggesting we need more education, better tools, and deeper self-awareness, not just prettier dashboards. Striking the right balance Digital well-being today is about making tech work for you, not walking away from it. With the right tools and clear boundaries, 2025 can be the year we finally learn how to log on without losing ourselves.


Hindustan Times
2 hours ago
- Hindustan Times
Harnessing India's medical colleges in the fight against TB
India has made undeniable progress in its battle against tuberculosis (TB). The World Health Organization (WHO) acknowledged a 17.7% drop in TB incidence in the country from 237 to 195 per lakh population between 2015 and 2023 – double the pace observed globally. Despite these advancements, India continues to bear the highest TB burden globally1, making the goal of a TB-free India even more urgent. Against this backdrop, medical colleges have emerged as vital players in the national TB response - providing a template for other disease programmes to tap into their potential for a healthier India. TB (AFP) Harnessing India's vast network of medical colleges is a cornerstone of the nation's ambitious strategy to eliminate TB by 2025. These institutions have transitioned from peripheral actors to central pillars in the fight against TB, contributing significantly to nearly every facet of the National Tuberculosis Elimination Programme (NTEP). Medical colleges have evolved beyond tertiary referral centres to become critical nodes in India's public health infrastructure and the TB elimination response. They serve patients from both within and beyond their districts and states, offering significant potential for case detection not just in TB and respiratory departments, but across all specialties. Equipped with advanced laboratories and specialised centres, nearly all of India's 651 medical colleges are working closely with the NTEP. Notably, 336 medical colleges have centres dedicated to managing drug-resistant TB, a more complex and harder-to-treat form of the disease. With cutting-edge diagnostic tools and clinical expertise in handling health complications, these institutions are leading to better TB care and outcomes. In 2023, medical colleges notified nearly 14% of all TB cases in India – a clear sign of their growing role in this national effort. Medical colleges are playing an increasingly important role in responding to the emerging trends in the TB epidemic. Extra-pulmonary forms of the disease that occur outside the lungs are on the rise and are generally harder to detect and treat. It now makes up 20-24% of all TB cases in India, especially among people with weaker immunity. With their advanced labs, specialist departments, and tertiary care capacity, medical colleges are uniquely positioned to deliver the multi-disciplinary care required to detect and manage these harder-to-treat cases. Medical colleges are also well placed to design and implement innovative health solutions, with research and practice occurring side by side. For example, the Bharati Vidyapeeth Medical College in Pune repurposed its Family Adoption Programme – where each student engages with five families over three years – to integrate community-based TB screening into the existing medical curriculum. This not only helped detect cases in the community, but also taught students to recognise key TB symptoms, demonstrating a scalable model for active case finding. One of our standout achievements has been fostering global collaborations. The ongoing partnership between AIIMS Gorakhpur and Johns Hopkins University through the TB-Free Schools initiative aimed at early detection, treatment, and prevention of TB among students in residential schools, demonstrates how Indian medical colleges can drive impactful international engagement. As this model is scaled, it reinforces what we have long championed—that medical colleges, when systematically integrated with state health systems, are among the most cost-effective and scalable platforms for delivering high-impact TB interventions. By leveraging these institutions, we can enhance passive case finding, improve diagnosis, and ensure timely treatment. With a structured mechanism for accountability under NTEP, medical colleges can become hubs for TB management. Furthermore, they are instrumental in building a competent healthcare workforce by integrating practical, programme-oriented TB management skills into the medical curriculum, thereby preparing a new generation of doctors for the challenges of TB elimination. Through a structured framework of national, zonal, and state-level task forces, medical colleges contribute to operational research, generating vital evidence to refine public health strategies and improve patient outcomes. By embedding themselves within the community through initiatives like the Family Adoption Programme, they also bolster active case finding efforts, ensuring early diagnosis and treatment, thus playing an indispensable and multifaceted role in India's journey towards a TB-free future. For TB and other critical public health challenges, where understanding patient behavior, treatment barriers, and local epidemiology is critical, the ability of medical colleges to connect science with ground-level implementation is key to turning policy into real-world action. They have technical expertise to strengthen surveillance systems, research capacity to strengthen monitoring and evaluation, and educational mandate to build local capability through supportive supervision. The integration of medical colleges into the TB elimination framework has been one of the most strategic shifts under the NTEP. Medical colleges have redefined their role in public health, not only by contributing to TB management, but by setting a precedent for how academic institutions can anchor systemic change. Their success is not incidental; it is the result of sustained collaboration, institutional commitment, and a shared vision of making India TB-free. Importantly, the integration of medical colleges into the TB response offers a replicable framework for tackling other complex health challenges in India – such as anti-microbial resistance, non-communicable diseases, and neglected tropical diseases – through a blend of research, education, service delivery, and community engagement. This article is authored by Dr Ashok Bhardwaj, professor emeritus, MM Medical & Hospital College Solan, Himachal Pradesh and chairperson of the National Task Force for Medical Colleges under NTEP and Dr Bhupendra Tripathi, deputy director, Infectious Diseases and Vaccine Delivery, Gates Foundation, India.


Time of India
3 hours ago
- Time of India
AIIMS Bhopal detects dominance of new XFG Covid variant, finds no trace of Nimbus strain
Bhopal: AIIMS Bhopal is reporting 'no detection' of NB.1 ( Nimbus variant ) in their sequenced samples from Madhya Pradesh, despite its classification as a 'Variant Under Monitoring' by the WHO. AIIMS Bhopal's data shows the early dominance of XFG in MP, while NB.1.8.1 is more prominent in other regions like Delhi, Maharashtra, and Kerala. Regional Virology Laboratory at AIIMS Bhopal completed sequencing of 44 Covid-19 positive samples collected between May and June 2025. The samples originated from Bhopal (14), Gwalior (22), Tikamgarh (2), and Indore, Khargon, Chhindwara, Lalitpur, Sidhi, and Gaya (one each). Analysis showed XFG variant as the dominant strain, present in 28 of 44 samples (63.6%). This variant, which developed from the LF.7 variant, was initially identified in May 2025, increased through early June, and became exclusive by late June. XFG.3, a new sub-variant evolved from XFG lineage, appeared in 5 of the 28 XFG-positive samples. The LF.7 variant, which represented 50% of samples in May, gradually decreased until its complete absence by late June. Both XFG and LF.7 variants can affect vaccinated individuals but have only caused mild or asymptomatic infections. The WHO has not categorised them as 'Variants of Concern' or 'Variants Under Monitoring.' AIIMS Bhopal director Dr Ajai Singh said, "AIIMS Bhopal Regional Virology Laboratory is working with scientific rigor to ensure that no emerging viral variant goes undetected. The early detection of variants like XFG and its sub-lineages helps us understand the virus's behavior and take timely precautionary public health measures." Regular genomic sequencing serves as an essential component of epidemic preparedness and response. AIIMS Bhopal advocates for consistent genomic surveillance of SARS-CoV-2 as a crucial public health activity in Madhya Pradesh and adjacent regions. This surveillance strategy enables early detection, prompt intervention, and improved readiness against potential future Covid-19 outbreaks or emerging variants.